PPARG and relapsing-remitting multiple sclerosis: In this study, we demonstrate that the expression of PPARγ is decreased in monocytes of relapsing-remitting MS (RR-MS) patients and that MS-associated proinflammatory cytokines IFNγ and IL1β reduce PPARγ expression.